Skip to main content
Log in

Antineoplastics

Hypercalcaemia and lack of efficacy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Caner B, et al. Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma. Journal of Oncology Pharmacy Practice 28: 1645-1649, No. 7, Oct 2022. Available from: URL: http://doi.org/10.1177/10781552221077418

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1950, 44 (2023). https://doi.org/10.1007/s40278-023-36441-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36441-9

Navigation